A
Akari Therapeutics - ADR (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics - ADR (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD0.58
- USD0.60
- USD0.54
- USD2.45
- -36.40%
- --
- 146.67k
- 335.91k
- 23M
- 0.57
- -74.30%
Stock News
yesterday
This biotech is halting its work with Novo Nordisk and laying off more people
MarketWatch
yesterday
What Anthropic's $50 billion AI infrastructure investment means for these 3 portfolio stocks
CNBC
yesterday
'Forever layoffs' and disengagement for some, pay bumps for others: What's in store for the 2026 workplace, says new report
CNBC
yesterday
White House says October jobs and inflation data may never be released because of the shutdown
CNBC
